BioSpace News Archive

Cytox Awarded New Innovate UK Funding for Alzheimer’s Testing

Cytox is pleased to announce that, in partnership with Cardiff University, the company has been awarded funding by Innovate UK.

March 8, 2018
·
1 min read
FDA

FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch

Polyganics announced that the US Food and Drug Administration (FDA) has granted Polyganics’ request for Breakthrough Device designation to its Liver and Pancreas Sealant Patch.

March 8, 2018
·
2 min read
BioMidwest

DaVita Hosts Panel to Promote Women’s Health and Empowerment on World Kidney Day

Livestreamed event will cover topics such as health equity, transplantation and advocacy.

March 8, 2018
·
3 min read
Genetown

Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases

Financing proceeds will be used to advance RAD51 inhibitor toward the clinic and expand small-molecule synthetic lethality platform for oncology and autoimmune diseases.

March 8, 2018
·
5 min read
Pharm Country

NHF Launches 2018 Red Tie Campaign to Protect Access to Affordable, Quality Healthcare for People with Bleeding Disorders

NHF marks Bleeding Disorders Awareness Month and its 70th anniversary on March 8 with advocacy event on Capitol Hill

March 8, 2018
·
5 min read
Business

Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates

Positive SER-287 Phase 1b clinical and microbiome results support further development; Company plans to initiate next clinical trial in mid-2018.

March 8, 2018
·
16 min read
Business

Zipongo Adds Chief Medical Officer To The Team To Support Company’s Roll Out Of “FoodScripts™"

Dr. Dexter Shurney, MD, MBA, MBH joins company as Chief Medical Officer as Zipongo ramps development of Food as Medicine to tackle chronic disease.

March 8, 2018
·
4 min read
Drug Development

Aptinyx Presents Preclinical and Phase 1 Clinical Data from NYX-2925 at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics

Aptinyx Inc. announced they will present preclinical and early-stage clinical data from studies of the company’s lead product candidate, NYX-2925, at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics, March 7-10, 2018 in Rockville, MD.

March 8, 2018
·
2 min read
Pharm Country

Ortho Clinical Diagnostics Launches Ortho’s VITROS® C-peptide Assay

Assay is now commercially available in the U.S. and countries accepting CE Mark

March 8, 2018
·
4 min read
Business

Cantel Medical Reports Record Financial Results for its Second Quarter Fiscal Year 2018

Cantel Medical Corporation announced financial results for its second quarter ended January 31, 2018.

March 8, 2018
·
2 min read